Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

TV Drug Ads May Trim Lengthy Recitation of Side Effects

Don't Miss Out —
Follow us on:

Feb. 14 (Bloomberg) -- Lengthy lists of drug side effects recited in TV ads are so baffling they may cause consumers to overlook the worst harms of the medicine, U.S. regulators said.

The Food and Drug Administration is studying whether disclosure limited only to serious side effects would improve consumer understanding, according to an agency document posted online today. To cover lesser side effects, the FDA proposed simply adding a line about “potential additional risks.”

Advertisements urging consumers to try pills for sleeping, erection problems, arthritis, high blood pressure and scores of other ailments are required to carry warnings of side effects in their television commercials in the interest of full disclosure. The long lists, delivered in voiceover that have been parodied in comic routines, confuse consumers and minimize the most dangerous risks, the agency said in its posting.

“Our hypothesis is that, relative to inclusion of the full major statement, providing limited risk information along with the disclosure about additional risks will promote improved consumer perception and understanding of serious and actionable drug risks,” the FDA said in its document.

The FDA plans to survey 1,500 study participants about ads with varying ranges of side-effect disclosure, then measure their understanding of risk.

The pharmaceutical industry spent $3.1 billion on direct-to-consumer advertising in 2012, according to the Pew Charitable Trusts.

To contact the reporter on this story: Anna Edney in Washington at aedney@bloomberg.net

To contact the editor responsible for this story: Reg Gale at rgale5@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.